Breathonix, a spin-off company from the National University of Singapore (NUS), has developed a rapid breath test that can detect the SARS-CoV-2 virus within a minute. A joint trial between Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health Authority (DHA), and Breathonix, is taking place in Dubai. The company’s initial pilot study in 180 patients achieved a sensitivity of 93% and specificity of 95% with the machine learning algorithm.

University of Rhode researchers have developed a new Covid-19 saliva test that will be used across its campuses for screening and surveillance of the SARS-CoV-2 virus. The test is less invasive than other nasal swab tests, is both specific and sensitive, and can deliver results at lower costs.

Roche has announced the launch of the cobas SARS-CoV-2 Variant Set 1 test which detects and differentiates mutations that were found in Covid variants across the UK, Brazil, and South Africa. The research use laboratory test is expected to help scientists in tracking mutations and analysing the impact on vaccines, diagnostics, and therapeutics.